Elderly AML patients expressing high NCL expression levels in their bone marrow showed a median survival of 6 months while those expressing low NCL expression levels had a median survival of 15 months (Log Rank Mantel-Cox, P = 0.0164). Here, NUCLEOLIN is linked to acute myeloid leukemia.